{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-025559","form_type":"8-K","ticker":"IPSC","cik":"0001850119","company_name":"Century Therapeutics, Inc.","filed_at":"2025-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.296276+00:00","generated_at":"2026-05-24T12:14:13.058660+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Century Therapeutics FY2024 net loss $126.6M; discontinues ELiPSE-1, focuses on CNTY-308","bullets":["Net loss $126.6M for FY2024 ($136.7M in 2023); cash $220.1M, runway into Q4 2026.","Discontinued ELiPSE-1 Phase 1 trial for CNTY-101 in R/R NHL; data not transformational.","Pipeline re-prioritized to four programs led by CNTY-308 (CD19 CAR-iT); IND-enabling studies mid-2025.","First patient dosed in CALiPSO-1 Phase 1 trial for CNTY-101 in autoimmunity; CARAMEL IIT to start mid-2025.","Collaboration revenue from BMS $6.6M; R&D expenses $107.2M (up from $92.7M) driven by trial and manufacturing costs."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-025559","json":"https://secwatch.observer/filing/0001104659-25-025559.json","markdown":"https://secwatch.observer/filing/0001104659-25-025559.md","text":"https://secwatch.observer/filing/0001104659-25-025559.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850119/000110465925025559/0001104659-25-025559-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850119/000110465925025559/tm259654d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T12:14:13.058660+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}